medigraphic.com
Colegio de Medicina Interna de México.

2006, Number 2

<< Back Next >>

Med Int Mex 2006; 22 (2)

Hyperglycemia un the critically ill patient. Epiphenomena or risk factor?

Carrillo ER, González CA, Cedillo THI

Language: Spanish
References: 23
Page: 97-106
PDF size: 284.83 Kb.


ABSTRACT

The metabolic disturbances as hyperglycemia are frequent in the critically ill patient. This alteration is consequence of the immunometabolic imbalance and insulin resistance that occurs during local and systemic inflammatory response. Hyperglycemia increases morbidity and mortality in patients admitted to intensive care unit with diagnosis of sepsis, stroke, burns, ischemic disease and trauma. The tight control of glucose serum levels is important in the critical care setting, and is related to better outcome, thus it must be considered in protocols of management at the intensive care unit.


REFERENCES

  1. Robinson LE, Soeren M. Insulin resistance and hyperglycemia in critical illness. AACN Clinical Issues 2004;15:45-62

  2. Preiser J, Devos P, Van den Berghe G. Tight control of glycaemia in critically ill patient. Curr Opin Clin Nutr Metab Care 2002;5:533-7.

  3. Coursin D, Connery E, Ketzler J. Perioperative diabetic and hyperglucemic management issues. Crit Care Med 2004;32:4.

  4. Van den Berghe G, Zegher F, Bouillon R. Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998;13:1827-34.

  5. Gelfand RA, Mattthews.DE, Bier MD, et al. Role of counterregulatory hormones in the catabolic response to stress. J Clin Invest 1984;74:2238-48.

  6. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically illness: insulin dose versus glycemic control. Crit Care Med 2003;31:359-66.

  7. Van den Berghe G. Endocrine evaluation of patients with critical illness. J Clin Endocrinol Metab 2003;32:2.

  8. McCowen K. Malhotra. Bistrian. Endocrine and metabolic dysfunction syndromes in the critically ill. Stress-induced hyperglucemia. Crit Care Clin 2001:17:1.

  9. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553-91.

  10. Montory V, Bistrian B, MacMahon M. Hyperglucemia en acutely ill patient. JAMA 2002;288:2167-9.

  11. Mizock BA. Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Prac Res Clin Endocrinol Metab 2001;15:533-51.

  12. Solano T. Totaro R. Insulin therapy in critical ill patients. Curr Opin Clin Nutr Metab Care 2004;7:199-205.

  13. Senftleben U, Karin M. The IKK/NF-kB pathway. Crit Care 2002;30:18-22.

  14. Jeschke M. Klein D. Herndon D. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004;239:553-60.

  15. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patient with and without diabetes: a systematic overview. Lancet 2000;355:773-8.

  16. Goldberg P, Siegel M, Barret PW, et al. Implementation of a safe and effective insuline protocol in a medical intensive care unit. Diabetes Care 2004;27:461-7.

  17. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.

  18. Moulin T, Tatu L, Crepin-Leblond T, et al. The Besancon stroke registry: An acute stroke registry of 2,500 consecutive patients. Eur Neurol 1997;38:10-20.

  19. Akbary CM, Saouaf R, Barnhill DF, et al. Endothelium-dependent vasodilation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg 1998;28:687-94.

  20. Vasa F, Molich M. Prolonged critical illness management of long term acute care. Clin Chest Med 2001;22:1.

  21. Stoner HB, Little RA, Frayn KN, et al. The effect of sepsis on oxidation of carbohydrate and fat. Br J Surg 1983;70:32-5

  22. Rayfield EJ, Ault MJ, Keusch GT, et al. Infection and diabetes: The case for glucose control. Am J Med 1982;72:439-50.

  23. Losser MR, Bernard C, Beaudez JL, et al. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 1997;83:1566-74.




2020     |     www.medigraphic.com